Patents by Inventor Rachel Codd

Rachel Codd has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • LIGANDS AND THEIR USE
    Publication number: 20250025582
    Abstract: This disclosure relates to compounds that include a first chelating ligand selective for 89Zr linked by a linker group to a second chelating ligand selective for a radionuclide other than 89Zr. Also disclosed are complexes, pharmaceutical agents and compositions comprising the compounds. The disclosure also provides methods for the use and production of the compounds, complexes, pharmaceutical agents and compositions.
    Type: Application
    Filed: December 22, 2021
    Publication date: January 23, 2025
    Inventors: Rachel CODD, James Liam WOOD, Christopher John McCormack BROWN
  • Desferrioxamine conjugates, derivatives and analogues
    Patent number: 8309583
    Abstract: The present invention relates to desferoxamine conjugates, derivatives and analogues thereof. In particular, the present invention relates to desferoxamine conjugates, analogues and derivatives thereof, and methods for reducing levels of metals, especially iron, in a mammal. Uses of the compounds according to the invention are also provided. Compounds of the present invention may also be used to treat iron dyshomeostasis disorders, cancer, malaria and fungal infections. The compounds of the invention may be formulated into a pharmaceutical composition or packaged into kits.
    Type: Grant
    Filed: October 31, 2008
    Date of Patent: November 13, 2012
    Inventors: Rachel Codd, Liam Grant Schipanski
  • DESFERRIOXAMINE CONJUGATES, DERIVATIVES AND ANALOGUES
    Publication number: 20100273847
    Abstract: The present invention relates to desferoxamine conjugates, derivatives and analogues thereof. In particular, the present invention relates to desferoxamine conjugates, analogues and derivatives thereof, and methods for reducing levels of metals, especially iron, in a mammal. Uses of the compounds according to the invention are also provided. Compounds of the present invention may also be used to treat iron dyshomeostasis disorders, cancer, malaria and fungal infections. The compounds of the invention may be formulated into a pharmaceutical composition or packaged into kits.
    Type: Application
    Filed: October 31, 2008
    Publication date: October 28, 2010
    Inventors: Rachel Codd, Liam Grant Schipanski